Treatment of Alzheimer Disease

Dear Colleagues,

Alzheimer’s disease (AD) is the most common neurodegenerative disease that represents the principal cause of dementia worldwide. The social and economic burden behind this disease affects families, caregivers and, obviously, patients. Numerous factors are involved in the onset and progression of AD, but the exact mechanisms leading to the accumulation of β-amyloid (Aβ) protein and the formation of neurofibrillary tangles of tau protein in the brain are still unresolved. In addition to the effort spent searching for new innovative treatments which are able to stop the progression of AD, to date, all treatments available are only applicable to symptomatic patients. Thus, the identification of modifications that accumulate with aging in the AD brain is certainly needed to discover new successful therapeutic approaches.

In this Special Issue, “Treatment of Alzheimer Disease”, we invite investigators to contribute original research articles and review articles regarding the novel therapeutic approaches to counteract AD progression.

Dr. Giulia Sita
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.